Silk Road Medical (SILK) PT Lowered to $52 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SILK Hot Sheet
Price: $27.49 --0%
Rating Summary:
4 Buy, 7 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 13 | New: 1
Rating Summary:
4 Buy, 7 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 13 | New: 1
Join SI Premium – FREE
JPMorgan analyst Robbie Marcus lowered the price target on Silk Road Medical (NASDAQ: SILK) to $52.00 (from $62.00) while maintaining a Overweight rating.
You May Also Be Interested In
- NICE Systems Ltd (NICE) PT Lowered to $158 at Citizens on Mixed Q3 Results
- Flutter Entertainment (FLUT) PT Lowered to $116 at Citizens on Q3 Miss 'Driven by Bad Game Outcomes'
- Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK312 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
